Prelude Therapeutics (PRLD) Stock Chart & Stock Price History $1.19 +0.05 (+3.93%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$1.18 -0.01 (-0.84%) As of 04:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prelude Therapeutics Stock Price Performance 5 Day Performance-2.06%1 Month Performance-6.67%3 Month Performance-0.83%6 Month Performance-81.32%Year-To-Date Performance-6.67%1 Year Performance-63.72% Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PRLD Stock Chart for Friday, January, 31, 2025 PRLD Chart by TradingView Prelude Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/30/2025$1.15$1.19+3.93%$1.22$1.10141,030 shs$65.49 million01/29/2025$1.14$1.15+0.44%$1.20$1.08156,901 shs$63.01 million01/28/2025$1.13$1.14+0.88%$1.14$1.06129,927 shs$62.73 million01/27/2025$1.22$1.13-7.00%$1.22$1.12125,710 shs$62.18 million01/24/2025$1.14$1.22+6.58%$1.27$1.13240,477 shs$66.86 million01/23/2025$1.17$1.14-2.56%$1.18$1.05171,478 shs$62.73 million01/22/2025$1.22$1.17-4.10%$1.31$1.15333,949 shs$64.39 million01/21/2025$1.05$1.22+16.19%$1.30$1.05901,000 shs$67.14 million01/20/2025$1.05$1.05$1.06$0.99146,770 shs$57.78 million01/17/2025$1.02$1.05+2.94%$1.06$0.99146,770 shs$57.78 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/16/2025$1.03$1.02-0.97%$1.06$0.99232,968 shs$56.13 million01/15/2025$1.02$1.03+0.98%$1.05$1.0183,207 shs$56.69 million01/14/2025$1.03$1.02-0.97%$1.07$1.00137,794 shs$56.14 million01/13/2025$1.06$1.03-2.83%$1.08$0.98397,642 shs$56.69 million01/10/2025$1.14$1.06-7.02%$1.16$1.03327,253 shs$58.34 million01/09/2025$1.14$1.14$1.26$1.13243,142 shs$62.74 million01/08/2025$1.21$1.14-5.79%$1.26$1.13243,142 shs$62.74 million01/07/2025$1.33$1.21-9.02%$1.33$1.15280,774 shs$66.59 million01/06/2025$1.39$1.33-4.32%$1.43$1.29271,041 shs$73.20 million01/03/2025$1.25$1.39+11.20%$1.41$1.30455,202 shs$76.50 million01/02/2025$1.28$1.25-1.96%$1.29$1.21309,727 shs$68.79 million01/01/2025$1.28$1.28$1.34$1.17616,197 shs$70.17 million12/31/2024$1.21$1.28+5.37%$1.34$1.17616,197 shs$70.17 million12/30/2024$1.34$1.21-9.70%$1.38$1.12907,529 shs$66.59 million Related Companies Amarin Stock Price Chart Zhengye Biotechnology Stock Price Chart Gossamer Bio Stock Price Chart Candel Therapeutics Stock Price Chart Molecular Partners Stock Price Chart Fulcrum Therapeutics Stock Price Chart Larimar Therapeutics Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Aurora Cannabis Stock Price Chart Ocugen Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
